Surgery vs SABR

Question 1

Who is SABR intended for?

Answer 1

• Stage I-II patients
• Elderly patients
• COPD

Question 2

What are the advantages of SABR?

Answer 2

• Better tumour control
• less dose to OAR
• Convenience (fewer #)

Question 3

What are the dose and # guidelines for SABR? ***

Answer 3

• 54Gy in 3#, 5-8 days
• 55Gy in 5# - 10-14 days
• 60Gy in 5# - 10-14 days
• 60Gy in 8# - 10-20 days

Question 4

What did the VIOLET study look at?

Answer 4

• Compare VATS with open surgery
• physical function post-surgery
• adverse effects
• disease-specific outcomes and survival
• Initial findings show shorter hospital stay

Question 5

What did the STARS trial assess?

Answer 5

• Open or VATS
• SABR was 54 in 3# (periph)
• 50 in 4# (central)

Question 6

What did ROSEL trial assess?

Answer 6

• Open or VATS
• SABR was 54 in 3#
• Central lesions were excluded